Hyphens Pharma (SGX:1J5), through Hyphens Pharma International, launched Winlevi (clascoterone) cream 1% in Singapore and Malaysia, according to a Thursday filing with the Singapore Exchange.
Shares of the company were up nearly 2% in recent trading.
The launch comes after the company entered into an exclusive license and supply agreement with Cosmo Pharmaceuticals subsidiary Cassiopea.
The acne cream provides treatment for acne-related inflammation.